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Escherichia coli O157:H7 and other pathogenic E. coli strains are enteric pathogens asso-
ciated with food safety threats and which remain a signiﬁcant cause of morbidity and
mortality worldwide. In the current study, we investigated whether enterohemorrhagic E.
coli (EHEC), Shiga toxin-producing E. coli (STEC), and enteropathogenic E. coli (EPEC)
strains can be rapidly and speciﬁcally differentiated with multiplex PCR (mPCR) utilizing
selected biomarkers associated with each strain’s respective virulence genotype. Primers
were designed to amplify multiple intimin (eae) and long polar ﬁmbriae (lpfA) variants, the
bundle-forming pilus gene bfpA, and the Shiga toxin-encoding genes stx1 and stx2. We
demonstrated consistent ampliﬁcation of genes speciﬁc to the prototype EHEC O157:H7
EDL933 (lpfA1-3, lpfA2-2, stx1, stx2, and eae-γ) and EPECO127:H6 E2348/69 (eae-α, lpfA1-
1, and bfpA) strains using the optimizedmPCRprotocolwith puriﬁed genomicDNA (gDNA).
A screen of gDNA from isolates in a diarrheagenic E. coli collection revealed that the
mPCR assay was successful in predicting the correct pathotype of EPEC and EHEC clones
grouped in the distinctive phylogenetic disease clusters EPEC1 and EHEC1, andwas able to
differentiate EHEC1 from EHEC2 clusters.The assay detection threshold was 2× 104 CFU
per PCR reaction for EHEC and EPEC. mPCR was also used to screen Argentinean clinical
samples from hemolytic uremic syndrome and diarrheal patients, resulting in 91% sensi-
tivity and 84% speciﬁcity when compared to establishedmolecular diagnostic procedures.
In conclusion, our mPCR methodology permitted differentiation of EPEC, STEC and EHEC
strains from other pathogenic E. coli ; therefore, the assay becomes an additional tool for
rapid diagnosis of these organisms.
Keywords: Shiga toxin-producing E. coli, enterohemorrhagic E. coli, enteropathogenic E. coli, E. coli O157,
diagnostics
INTRODUCTION
Rapid diagnosis of pathogenic E. coli strains is an increasingly
important issue to address in public health. Infections with Shiga
toxin-producing E. coli (STEC) and among those enterohemor-
rhagic E. coli (EHEC), can result in abdominal cramping and
diarrhea (with or without blood). A small percentage of patients
can progress to a more severe and often fatal condition called
hemolytic uremic syndrome (HUS). STEC/EHEC strains are
found in industrialized nations as well as developing countries and
typical cases in theU.S. are associatedwith food-borne contamina-
tion. EnteropathogenicE. coli (EPEC) is frequently associatedwith
outbreaks of infantile diarrhea indevelopingnations (Orskov et al.,
1990), and is a contributor to diarrheagenic illnesses in human
populations around the world (Ochoa et al., 2008).
Shiga toxin-producing E. coli/EHEC and EPEC strains encode
a number of virulence factors in a chromosomally located
pathogenicity island termed the locus for enterocyte effacement
(LEE; McDaniel et al., 1995). Intimate adhesion of STEC/EHEC
and EPEC to enterocytes is mediated in part by LEE-encoded
intimin gene (eae), resulting in the formation of an attaching and
effacing (A/E) lesion on the surface of the intestinal cells. In addi-
tion to virulence factors encoded in the LEE pathogenicity island,
EHEC and EPEC possess one or more of the chromosomally
encoded long polar ﬁmbriae (lpf) loci. Together with intimin, Lpf
is the only other well-characterized colonization factor of EHEC
O157:H7 (Torres et al., 2002, 2004, 2007). Our group conducted
an extensive study involving A/E-producing bacterial collections
from Europe and South America and demonstrated a correlation
between lpf genes and different genetic variants of the intimin
genes in A/E-producing E. coli (AEEC; Torres et al., 2009). The
lpf genes are also widely distributed throughout pathogenic and
some commensal populations of E. coli and can be categorized
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into distinct allelic variants (Galli et al., 2010; Gomes et al., 2011).
Additionally, other groups have also reported the potential use of
intimin for diagnostics based on the correlation of intimin type
and lineage of STEC/EHEC and EPEC strains (Tarr and Whittam,
2002; Zhang et al., 2002; Jores et al., 2003). Due to the broad dis-
tribution of lpf and eae genes in AEEC and their association with
these pathogenic E. coli strains, the lpf and eae subtypes could be
used to genetically identify and distinguish diverse STEC/EHEC
and EPEC serogroups (Torres et al., 2009). From a clinical point of
view, the inclusion of primers for stx genes is critical, as the pro-
gression to HUS is strongly inﬂuenced by the presence of Shiga
toxin (Friedrich et al., 2002; Brooks et al., 2005; Hedican et al.,
2009). Further, the bfpA gene can be used as marker to detect typ-
ical (bfp+) and atypical (bfp−) EPEC strains (Nataro and Kaper,
1998).
Current proposed approaches for the speciﬁc detection of
EHEC strains in clinical samples or food matrices are focused on
thedetectionof genes present in a limitednumber of serotypes. For
example, the inclusion of the E. coli O157:H7 O-antigen marker
rfbEO157 limits the detection of strains to O157 serogroups (Bai
et al., 2010; Gordillo et al., 2011). Analysis of multiple O-group
genes improves the detection capabilities of an assay, but does not
remove the constraint of detecting only known serogroups (Madic
et al., 2011). Similar constraints are present when targeting the H7
ﬂiC ﬂagellar antigen (Madic et al., 2010; Gordillo et al., 2011)
or when employing O157 strain-speciﬁc methodologies (Ooka
et al., 2009). A recent study utilized genes encoding intimin and
Shiga toxin to detect EHEC and EPEC strains, yet the assay was
not designed to speciﬁcally detect O157 strains (Pavlovic et al.,
2010).
In developing countries, enteric pathogen identiﬁcation is
frequently time consuming and incomplete, resulting in poten-
tial misdiagnoses or mistreatments. Therefore, a rapid, spe-
ciﬁc assay designed to identify EHEC/STEC and EPEC strains
in a public health setting would be advantageous to help
ensure that a timely and proper response is initiated. Fur-
thermore, assays like this one would accelerate the diagno-
sis and signiﬁcantly reduce mortality in endemic areas. Spe-
ciﬁc identiﬁcation of highly pathogenic EHEC would also
be critical in the event of food-borne illness outbreaks or
agroterrorism.
Therefore, our study addresses the aforementioned constraints
on the detection of these diarrheagenic E. coli (DEC) cate-
gories by using genes that do not encode serogroup-speciﬁc anti-
gens, yet can distinguish O157:H7 strains, as well as unknown
serogroups. We examined the hypothesis that re-emerging and
outbreak-associated E. coli strains can be rapidly, speciﬁcally,
and easily distinguished using multiplex PCR (mPCR) ampliﬁca-
tion of speciﬁc biomarkers associated with each strain’s respec-
tive virulence genotype. The results of our mPCR assay indi-
cate that this approach can provide a rapid method for detec-
tion of pathogenic E. coli strains. We demonstrated that lpfA
subtypes could distinguish between EHEC and EPEC groups
and most importantly, inclusion of lpfA variants permitted
detection of EHEC O157:H7 in 100% of the cases, further
supporting the importance of lpfA in molecular diagnostics
approaches.
MATERIALS AND METHODS
STRAINS
Enterohemorrhagic E. coli O157:H7 strain EDL933, EPEC
O127:H6 strain E2348/69, E. coli K12 strain MG1655, E. coli HS,
Salmonella enterica serovar Typhimurium 2157, Shigella ﬂexneri
M90T, adherent invasiveE. coli O83:H1NRG857c, enterotoxigenic
E. coli H10407, enteroaggregative E. coli O42, and 78 isolates from
the DEC Collection (Whittam et al., 1993) were grown in Luria–
Bertani (LB) broth at 37˚C with shaking. Genomic DNA (gDNA)
was extracted from the cells using the DNeasy Blood and Tissue
Kit (Qiagen, Valencia, CA, USA).
PCR
Single and mPCR reactions were carried out using REDTaq
ReadyMix PCR Reaction Mix and REDTaq DNA Polymerase
(Sigma, St. Louis, MO, USA) supplemented with the appropri-
ate primers and template DNA. Oligonucleotide primer sequences
wereused frompreviously publishedworkormanually designed to
obtain amplicons of sufﬁciently different sizes to be resolved in the
multiplex assay (Tables 1 and 2). Primer sets speciﬁcally designed
in this study utilized sequences for eae-α (FM180568), eae-β
(AF081186), eae-γ (AE005174), eae-δ (AJ875027), and lpfA1-1
(NC_011601). Single PCR reactions using REDTaq ReadyMix
(Sigma, St. Louis,MO,USA) and 0.8mM of each primer were per-
formed under the following conditions: 94˚C for 5min; 30 cycles
of 94˚C for 30 s, 42˚C for 45 s, 72˚C for 35 s; 72˚C for 10min; hold at
10˚C. Multiplex reactions using an additional 0.8 units of REDTaq
DNA polymerase (1.4 units total per reaction – supplementation
with extra polymerase permitted an increase in speciﬁcity and
band intensity) were performed under the following conditions
using the primer concentrations indicated in Table 1: 94˚C for
5min; 40 cycles of 94˚C for 30 s, 59˚C for 1min 30 s, 72˚C for 40 s;
72˚C for 10min; hold at 10˚C. Products were analyzed on 1.5%
agarose gels.
THRESHOLD OF MULTIPLEX PCR ASSAY DETECTION
The assay was performed by ﬁrst re-suspending cells (EHEC
O157:H7 EDL933 or EPEC O127:H6 E2348/69) freshly streaked
onto LB agar to an estimated concentration of ∼4× 109 cells/ml
by monitoring the OD600. Ten-fold serial dilutions were made into
sterile distilled water, which was then used as template directly in
mPCR reactions.
ISOLATION AND MOLECULAR CHARACTERIZATION OF CLINICAL
STRAINS
One hundred fecal samples (43 HUS, 36 non-bloody diarrhea,
and 21 bloody diarrhea cases) submitted to the National Refer-
ence Laboratory (NRL) in Buenos Aires, Argentina were studied.
Fecal samples were plated either directly onto sorbitol Mac-
Conkey agar or after enrichment at 37˚C for 4 h in trypticase soy
broth with or without ceﬁxime (50 ng/ml) and potassium tellu-
rite (25mg/ml). Conﬂuent growth zones were ﬁrst screened for
stx1, stx2, and rfbO157 genes by mPCR (Leotta et al., 2005). A
single PCR targeting the eae gene was performed (Karch et al.,
1993; Karch and Bielaszewska, 2001) as well as testing of the
eae variants (Ramachandran et al., 2003), if mPCR for the stx1,
stx2, and rfbO157 genes was negative. Isolates with stx1, stx2,
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Table 1 |Virulence-associated genes and primers used in this study.
Target Primer sequences Primer conc. in multiplex PCR (mM) Amplicon size (bp) Reference
stx2-F 5′-ATCCTATTCCCGGGAGTTTACG-3′ 1 587 Cebula et al. (1995)
stx2-R 5′-GCGTCATCGTATACACAGGAGC-3′ 1
eae-γ-F 5′-CAGGTTGGGGTAACGGACTTTAC-3′ 1 472 This study
eae-γ-R 5′-TTGCTTGCGTTTGAGACTTACCGTTG-3′ 1
lpfA1-1-F 5′-GTGCTGGATTCACCACTATTCATCGC-3′ 0.2 389 This study
lpfA1-1-R 5′-GCCTTGTCTGCACTGGCATTAACTTC-3′ 0.2
stx1-F 5′-CAGTTAATGTGGTKGCGAAGG-3′ 1 348 Cebula et al. (1995)
stx1-R 5′-CACCAGACAATGTAACCGCTG-3′ 1
bfpA-F 5′-AATGGTGCTTGCGCTTGCTGC-3′ 0.2 326 Aranda et al. (2007)
bfpA-R 5′-GCCGCTTTATCCAACCTGGTA-3′ 0.2
lpfA2-2-F 5′-CTACAGGCGGCTGATGGAACA-3′ 0.2 297 Torres et al. (2009)
lpfA2-2-R 5′-GCTAATACCAGCGGCAGCATCGT-3′ 0.2
lpfA1-3-F 5′-GGTTGGTGACAAATCCCCG-3′ 0.2 244 Torres et al. (2009)
lpfA1-3-R 5′-CGTCTGGCCTTTACTCAGA-3′ 0.2
eae-F 5′-CTTTGACGGTAGTTCACTGGACTTC-3′ 0.2 166 This study
eae-R 5′-GAAGACGTTATAGCCCAACATATTTTCAGG-3′ 0.2
Table 2 | Gene profiles for differentiation of E. coli pathotypes.
Pathotype (serotype) Gene targets in multiplex PCR assay
eae lpfA stx bfpA
EHEC (O157:H7) eae-γ lpfA1-3 and lpfA2-2 stx1 and/or stx2 NA
STEC various eae Various lpf stx1 and/or stx2 NA
LEE− – STEC NA lpfA1-2 and/or lpfA2-1 stx1 and/or stx2 NA
Typical EPEC (O127:H6) eae-α lpfA1-1 NA bfpA
Atypical EPEC eae-β lpfA1-2 and/or lpfA2-1 stx1 and/or stx2 NA
NA, not applicable.
and/or eae genes were identiﬁed by standard biochemical tests,
serotyped, and characterized by phenotypic and genotypic tech-
niques (Rivas et al., 2011). For comparison purposes, the same
DNA templates were screened by the mPCR developed in the
present study using Platinum Taq DNA Polymerase (Invitrogen,
Brazil). This study was carried out in strict accordance with the
Guidelines of the National Institutes of Health and the Ministry
of Health, Argentina. The protocol was approved by the Institu-
tional Review Board of the University of Texas Medical Branch
(IRB#11-081).
RESULTS
MULTIPLEX PCR ANALYSIS OF STRAINS FROM A DIARRHEAGENIC
E. COLI COLLECTION
The present work describes the development of an mPCR assay for
the rapid detection of speciﬁc categories of pathogenic E. coli. The
assay is based on the use of pathotype-speciﬁc genes for the detec-
tion of medically relevant E. coli strains, and is able to speciﬁcally
detect EHEC, typical and atypical EPEC, and STEC strains.
We demonstrated robust ampliﬁcation of genes speciﬁc to
EHEC O157:H7 strain EDL933 (lpfA1-3, lpfA2-2, stx1, stx2, and
eae-γ) and EPEC O127:H6 strain E2348/69 (eae-α, lpfA1-1, and
bfpA) using an optimized mPCR protocol with puriﬁed gDNA.
Ampliﬁcation of genes encoding virulence factors speciﬁc to
pathogenic E. coli (Table 2) was ﬁrst tested in single PCR reactions.
One ampliﬁcation product was observed in each case (data not
shown). During optimization of the multiplex reaction, the addi-
tion of REDTaq DNA polymerase to the polymerase already
present in the 1× solution of REDTaq ReadyMix permitted an
increase in the annealing temperature (thereby increasing speci-
ﬁcity) and robustness of the assay. Modiﬁcation of primer con-
centration, total number of cycles, and primer annealing time
were also optimized. To assess the efﬁcacy of this assay on clin-
ical isolates, gDNA from strains in the DEC collection (Whittam
et al., 1993), representing a variety of serotypes from the EHEC
(clonal groups EHEC1 and EHEC2) and EPEC (clonal groups
EPEC1 and EPEC2),was screened using mPCR (Figure 1). Ampli-
con sizes from each DEC sample were compared to those in
the control strains to compose a genotype for each representa-
tive DEC group member. We determined that mPCR analysis
using gDNA from DEC isolates was successful in predicting the
correct pathotype in 75.6% (59/78) of the total number of iso-
lates; however the assay was able to predict the pathotype of all
EHEC1 (DECs 3, 4, and 5) and EPEC1 (DECs 1 and 2) and
distinguish between EHEC1 and EHEC2 (DECs 8, 9, and 10)
pathogroups.
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FIGURE 1 | Multiplex PCR screening of representatives from each diarrheagenic E. coli collection (DEC) group. (A) DEC 1–8; (B) DEC 9–15, M – 100bp
DNA markers (NEB). EHEC/EPEC, positive controls; (−), no template control.
FIGURE 2 | Determination of biological assay specificity. Multiplex PCR
assay was performed using gDNA from pathogenic and commensal enteric
bacteria. M, 100 bp DNA markers (NEB); EHEC, enterohemorrhagic E. coli ;
EPEC, enteropathogenic E. coli ; E. coli HS and E. coli K12, human intestinal
commensal and laboratory strains; S. ﬂexneri, Shigella ﬂexneri ; S.
typhimurium, Salmonella enterica serovar Typhimurium 2157; ETEC,
enterotoxigenic E. coli H10407; EAEC, enteroaggregative E. coli O42;
AIEC, adherent/invasive E. coli O83:H1; (−), no template control. The
position of the amplicons in the EHEC and EPEC strains are indicated on
the right of the ﬁgure.
ANALYTICAL SENSITIVITY OF MULTIPLEX PCR ASSAY
To assess the speciﬁcity of the assay, the multiplex reaction setup
was tested using gDNA from commensal E. coli strains and path-
ogenic enteric bacteria. Relatively low intensity amplicons slightly
larger than the size of the eae product were observed in three of
the seven strains tested (two E. coli strains [one commensal and
one laboratory isolate] and Shigella ﬂexneri; Figure 2). With the
Salmonella strain used, we observed a product of approximately
300 bp, possibly due to ampliﬁcation of an uncharacterized lpfA
variant in that strain. A smaller, faint amplicon was also observed
using the Salmonella strain; however, its size does not correspond
to any of the amplicons expected in our assay. Analysis of the com-
mensal E. coli HS revealed another faint, non-speciﬁc product not
corresponding to the size of a target amplicon (Figure 2).
ANALYTICAL SPECIFICITY OF MULTIPLEX PCR ASSAY
We then determined the in vitro threshold of detection with the
EHEC and EPEC prototype strains. Colonies from freshly streaked
LB agar plates were re-suspended in sterile distilled water to a con-
centration of ∼4× 109 cells/mL. A 5μl aliquot from each of the
10-fold serial dilutions were added to mPCR reactions to per-
mit testing of a 10-fold range of template concentrations from
1× 109 to 1× 103 cells/mL in a 20μl reaction. The threshold of
detection for EHEC and EPEC in vitro was determined to be
∼2× 104 CFU/reaction (corresponding to 1× 106 cells/ml in each
reaction), assessed by visibility of all six predicted amplicons for
EHEC and all three amplicons for EPEC (Figure 3).
EVALUATION OF MULTIPLEX PCR ASSAY AT NRL (ARGENTINA)
Next, we tested the feasibility to implement our mPCR in a clin-
ical setting, performing a trial study with samples received at the
National Reference Laboratory (NRL), Argentina, and compar-
ing the results to methods already optimized in that laboratory
(Table 3). The clinical sensitivity and speciﬁcity of the assay was
estimated to be 91% and 84%, respectively. Identiﬁcation of at
least one gene (eae, one of the stx genes, or rfbO157 ) was the basis
for determining whether a given case was considered positive or
negative.
Further analysis of non-O157 and non-O145 isolates revealed
that although the mPCR assay typically identiﬁed eae-γ in these
isolates, RFLP–PCR intimin typing (Ramachandran et al., 2003) at
the NRL revealed eae-β or eae-θ in the non-O157 and non-O145
cases (data not shown). These ﬁndings likely represent a false pos-
itive indication of the presence of eae-γ, as strains that possess
eae-γ typically contain lpfA1-3 and lpfA2-2 as well, both of which
are absent in the eae-β and eae-θ strains.
Inonepositive case (Table 3, isolate 4), themPCRassaywaspos-
itive for both stx1 and stx2, while the stx-negative result at the NRL
was conﬁrmed using RFLP–PCR (Tyler et al., 1991; Zhang et al.,
2002). In two other cases, the standardmethodology revealed eae+
strains, whereas the mPCR assay indicated that the strains lacked
intimin (Table 3, isolates 31 and 32). Interestingly, analysis of iso-
lates 30–34 revealed that the mPCR produced amplicons for both
lpfA1-3 and lpfA2-2only (Table 3). Despite indicating a positive
result for two of the markers for O157:H7 strains, that serotype
was not conﬁrmed in those isolates (Table 3).
In the 11 cases where the NRL indicated negative results and
the mPCR assay indicated positive results (Table 3, isolates 90–96,
97, 100), nine of them were considered false positives for eae, as
they were further conﬁrmed to be negative for eae subtypes by
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FIGURE 3 | Determination of detection threshold. Serial dilutions of
re-suspended EHEC EDL933 or EPEC E2348/69 colonies were used
as template in the multiplex PCR reaction. M – 100bp DNA markers
(NEB). Number above each lane indicates the concentration (cells/ml)
of bacteria per reaction. Consistent detection of (A) all of six EHEC
EDL933-speciﬁc bands and (B) all three EPEC E2348/69-speciﬁc
bands was observed using 2×104 cells in a 20μl PCR reaction. ×,
lane was not loaded; (−), no template control. The position of the
amplicons in the EHEC and EPEC strains are indicated on the right of
each panel.
RFLP–PCR. Two strains identiﬁed by the described mPCR assay
as either stx1+ (Table 3, isolate 100) or stx2+ (Table 3, isolate 97)
were conﬁrmed as stx-negative by RFLP–PCR.
While the assay can reliably detect EHEC, STEC, and typical or
atypical EPEC strains, the repertoire of pathotype detection can
be expanded by the inclusion of primers for lpfA1-2 and lpfA2-1.
The LEE− negative STEC typically possess one or both of these
lpfA subtypes (Galli et al., 2010; Gomes et al., 2011). Additionally,
detection of lpfA1-2 and/or lpfA2-1 permits the differentiation of
strains from the EHEC2 (DECs 8, 9, and 10) and EPEC2 (DECs 11
and 12) clonal groups (Figure 4, data not shown). The EHEC
and EPEC pathotypes were identiﬁed after examining a num-
ber of diarrheagenic strains by multilocus enzyme electrophoresis
and serotyping, and appear to represent distinct clonal lineages of
pathogenic E. coli (Whittam and McGraw, 1996; Reid et al., 2000).
The unique ability of the multiplex assay to speciﬁcally detect
EHEC and EPEC clonal groups is predominantly conferred by
lpfA subtype analyses (Figure 4). Using DEC collection isolates
(Whittam et al., 1993), clonal group EHEC1 (DECs 3, 4, and
5) were detected, in part, by the inclusion of primers amplifying
EHECO157:H7-speciﬁc lpfA subtypes 1-3 and 2-2. EPEC1 isolates
(DECs 1 and 2) and EPEC O127:H6 were speciﬁcally identiﬁed by
the ampliﬁcation of lpfA1-1. The addition of lpfA subtyping was
advantageous since lpfA subtypes differ among EHEC and EPEC
clonal groups (Torres et al., 2009). As such, it permitted us to dif-
ferentiate the more common EHEC1 and EPEC1 clonal groups
from members of the EHEC2 and EPEC2 categories, respec-
tively. Further speciﬁcity was conveyed by the ampliﬁcation of
pathotype-speciﬁc intimin subtypes: γ-intimin was used to detect
EHEC1 isolates and α-intimin was used to detect EPEC1 isolates.
DISCUSSION
A panel of eight genes was employed for the design of a sensitive
and speciﬁc mPCR assay to facilitate detection of three pathotypes
of E. coli that cause signiﬁcant morbidity and mortality across the
world – EHEC, STEC, and EPEC. The assay was also designed to be
relatively low-cost, as compared to the ﬁnancial burden of acquir-
ing instrumentation and consumables to perform real-time PCR
ormultiplex bead-based assays. A collection of DEC strains (Whit-
tam et al., 1993) was tested using the assay, and we demonstrated a
relatively high degree of agreement between the mPCR results and
strain information present in the DEC database. Evaluation of the
speciﬁcity revealed no signiﬁcant cross-reactivity of the primers
with other E. coli pathotypes. The detection threshold of the assay
was determined to be comparable to other PCR-based methods
for detection of E. coli isolates (Aranda et al., 2007; Antikainen
et al., 2009; Vidová et al., 2011). Of particular signiﬁcance is the
observation that deﬁned combinations of lpfA subtypes permitted
differentiation of EHEC and EPEC clonal groups.
Both EHEC and EPEC are AEEC strains, possessing the LEE-
encoded gene products for development of the intestinal lesions
(McDaniel and Kaper, 1997). The presence of the LEE-encoded
adhesin intimin gene eae (Jerse and Kaper, 1991), is indicative
of these strains, and; therefore, a ﬁrst primer set was designed to
amplify only eae-γ, previously demonstrated to be associated with
the EHEC1 clonal group (Adu-Bobie et al., 1998; Reid et al., 1999).
The second eae primer set was engineered to be more generic,
amplifying the remaining major eae subtypes α, β, and δ (Adu-
Bobie et al., 1998). Importantly, intimin α is associated with the
EPEC1 clonal group, while intimin β is indicative of members of
the EPEC2 clonal group (Adu-Bobie et al., 1998; Reid et al., 1999).
Thus, themultiplex assay has the potential to detect a large number
of AEEC strains.
In the multiplex strategy, the addition of primers for lpfA sub-
typing conferred the greatest increase in the ability of the assay to
differentiate members of the EHEC and EPEC clonal groups. Lpf
are elaborated appendages important for pathogenesis and adher-
ence to cultured cells (Torres et al., 2002, 2004), persistence in
animal models (Jordan et al., 2004; Torres et al., 2007), and tissue
tropism in the human intestine (Fitzhenry et al., 2006). In addi-
tion, the combination of lpfA and eae subtyping can speciﬁcally
detect EHEC O157:H7 (Torres et al., 2009), providing a distinct
time advantage over more conventional culture- or immunoassay-
based methodologies for the detection of O157:H7 strains.
Primer sets for both Shiga toxin 1 (stx1) and Shiga toxin 2
(stx2) were incorporated into the assay to facilitate identiﬁcation
of STEC strains, because early detection is critical for determining
appropriate therapies for patients with suspected E. coli infec-
tions. Although there are a number of stx2 variants, we included
primers based on the E. coli O157:H7 stx2 sequence due to the link
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Table 3 | Comparison of results between molecular diagnostic assays at NRL and the current proposed mPCR methodology.
Results of assays1
Isolate no. (serotype)
Diagnosis2 PCR (NRL) mPCR (UTMB)
eae rfbO157 stx1 stx2 eae eae-γ stx1 stx2 lpfA1-3 lpfA2-2
NRL POSITIVE/mPCR POSITIVE
1 (ONT:motile) BD + − − − + + − − − −
2 (OR:motile) D + − − − + − − − − −
3 (O157:H7) BD + + − + + + − + + +
4 ND HUS + − − − + − + + − −
5 (O157:H7) HUS + + − + + + − + + +
6 (O157:H7) BD + + − + + + − + + +
7 (O145:NM) HUS + − − + + + − + − −
8 ND HUS + − + − + + + + − −
9 (O157:H7) BD + + − + + + − + + +
10 (O157:H7) HUS + + − + + + − + + +
11 (O157:H7) HUS + + − + + + − + + +
12 (O145:NM) D + − − + + + − + − −
13 (O157:H7) HUS + + − + + + − + + +
14 (ONT:motile) HUS + − − − + + − − − −
15 (O26:NM) BD + − − − + − − − − −
16 (O26:H11) D + − − + + + − + − −
17 (O145:NM) HUS + − − + + + − + − −
18 (O145:NM) HUS3 + − − + + + − + − −
19 (O145:NM) BD + − − + + + − + − −
20 ND D + − − − + − − − − −
21 ND D + − − − + + − − − −
22 (O145:NM) D + − − + + + − + − −
23 (O145:NM) D + − − + + + − + − −
24 (O157:H7) HUS + + − + + + − + + +
25 (O157:H7) BD + + − + + + − + + +
26 (ONT:H46) BD + − − + + − − + − −
27 (O145:HNM) HUS + − − + + + − + − −
28 (O157:HNT) HUS + + − − + − − − − −
29 (O157:H7) HUS + + − + + + − + + +
NRL POSITIVE/mPCR NEGATIVE
30 (O157:HNT) BD − + − − − − − − + +
31 ND D + − − − − − − − + +
32 ONT:HNT BD + − − − − − − − + +
NRL NEGATIVE/mPCR NEGATIVE
33 ND D − − − − − − − − + +
34 ND HUS − − − − − − − − + +
35−89 ND 23 D − − − − − − − − − −
9 BD − − − − − − − − − −
23 HUS − − − − − − − − − −
NRL NEGATIVE/mPCR POSITIVE
90 ND D − − − − + − − − − −
91 ND HUS − − − − + − − − − −
92 ND HUS − − − − + − − − − −
93 ND HUS − − − − + − − − − −
94 ND BD − − − − + − − − − −
95 ND HUS − − − − + − − − − −
96 ND HUS − − − − + − − − − −
97 ND BD − − − − − − − + − −
(Continued)
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Table 3 | Continued
Results of assays1 Diagnosis2 PCR (NRL) mPCR (UTMB)
Isolate no. (serotype) eae rfbO157 stx1 stx2 eae eae-γ stx1 stx2 lpfA1-3 lpfA2-2
98 ND D − − − − + − − − − −
99 ND D − − − − + − − − − −
100 ND D − − − − − − + − − −
1Positivity is deﬁned as genetic evidence for an O157, attaching/effacing-, or Shiga toxin-producing E. coli isolate.
2D, diarrhea; BD, blood diarrhea; HUS, hemolytic uremic syndrome.
3Patient died.
ND serotype not determined (unable to isolate a strain).
FIGURE 4 | Phylogeny and lpfA subtype of isolates in diarrheagenic
E. coli (DEC) collection. DEC clone numbers (Reid et al., 1999),
corresponding predominant serotype of the given group,
pathotype/intimin subtype, and information regarding lpfA subtype(s)
for each group are indicated (Adapted fromTorres, 1999 Ph.D.
Dissertation). The lpfA1-2 and lpfA2-1 were previously identiﬁed in
EHEC2 and EPEC2 isolates (Torres et al., 2009). ND, not determined
(none of the three lpfA subtypes included in the multiplex PCR were
detected, and lpfA subtypes were not studied further during the
multiplex PCR project).
between the development of HUS and the presence of stx2, partic-
ularly inO157:H7 strains (Friedrich et al., 2002; Brooks et al., 2005;
Hedican et al., 2009). Conversely, the assay is capable of detecting
non-O157 STEC,a groupof under-diagnosed emerging pathogens
(Coombes et al., 2011), and emerging LEE-negative STEC strains
(Newton et al., 2009; Galli et al., 2010).
To further expand the detection capabilities, primers to amplify
the bundle-forming pili subunit bfpA were incorporated into the
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assay. Because the bundle-forming pilus is a central virulence fac-
tor of EPEC strains, playing a putative role in initial attachment to
enterocytes (Cleary et al.,2004) andmicrocolony formation (Hicks
et al., 1998), the bfpA gene can be used as a marker for identiﬁ-
cation of typical EPEC (Nataro and Kaper, 1998) in conjunction
with eae (Giron et al., 1993).
Our mPCR results with DEC collection isolates suggest that
this approach will prove useful for rapid identiﬁcation of these
pathogenic E. coli strains. The incidence of non-speciﬁc ampli-
ﬁcation was low, and in many cases, the bands were faint
compared to the intensities of the primer-speciﬁc products
and outside the size range of the target amplicons (data not
shown). The presence of non-speciﬁc amplicons is not antic-
ipated to result in the misidentiﬁcation of strains as DEC,
and is not uncommon in mPCR approaches (Antikainen et al.,
2009).
The diagnostic sensitivity and speciﬁcity was calculated to be
91% and 84%, respectively, when comparing to the “standard”
methodology used by the NRL (Argentina) for routine detec-
tion of highly virulent STEC strains and our mPCR assay. These
data strongly suggest that the mPCR approach described here is
a relatively low-cost and feasible screening methodology for clin-
ical fecal samples within 24 h of obtaining a specimen. Because
Argentina possesses the highest incidence of post-enteric HUS in
infants and children in the world, and O157:H7 and O145:NM
are the most prevalent serotypes (Rivas et al., 2010, 2011), this
new mPCR approach permits rapid identiﬁcation of STEC strains
involved in the majority of the cases (>70%) received at the NRL.
Further, this method can also be used in areas where other STEC
or EPEC strains are prevalent.
Assay speciﬁcity was determined by screening additional E. coli
pathotypes, commensal E. coli, and a limited number of non-E.
coli intestinal pathogens. This analysis revealed that the assay is
highly speciﬁc; none of the unexpected ampliﬁcation products
correspond to the size of a predicted amplicon (Figure 2). Minor
cross-reactivity of the broad-range intimin primers with a putative
intimin gene in E. coli K12 (eaeH ) and E. coli HS (EcHS_A0351)
may account for the observation of a band migrating at approxi-
mately the same size as the speciﬁc intimin target observed using
EHEC or EPEC. However, S. ﬂexneri does not appear to possess a
putative intimin sequence.
The threshold detectionof ourmultiplex approachwas assessed
and the template concentrations at which all expected ampli-
cons were clearly visible on the gel was set as the limit for
detection of that pathotype. EHEC and EPEC were detectable
at or above 2 × 104 CFU per reaction (Figure 3). Compared
to other mPCR methodologies (Aranda et al., 2007; Antikainen
et al., 2009; Vidová et al., 2011), the sensitivities determined
here are slightly higher, perhaps owing to the selection of DNA
polymerase. The REDTaq Ready Mix was chosen based on the
premixed nature of the components, thereby reducing pipetting
errors and increasing reproducibility, and its relatively low-cost, a
factor critical for adoption of this assay in developing countries.
The balance between assay cost and sensitivity can be adjusted
based on the ﬁnancial resources of the testing facility, suggesting
that the purchase of more costly polymerases could increase assay
sensitivity.
The observation that lpfA and eae subtypes are related to spe-
ciﬁc EHEC and EPEC clonal groups provides evidence of the
lineage of pathogenic E. coli, but also permitted us to design an
assay exploiting these phylogenetic relationships (Figure 4). In its
current form, the mPCR assay can reliably distinguish strains in
the EHEC1 and EPEC1 clonal groups, atypical EPEC, and differ-
entiate O157 and non-O157 STEC strains. Interestingly, isolates
from the EPEC2 group (DEC 11 and DEC 12) were negative for
bfpA. This result likely reﬂects the speciﬁcity of the bfpA primer
set for the bfpAα1 allele present in the O127:H6 prototype EPEC
strain (Blank et al., 2000). Therefore, strategies for detection of
EPEC2 strains should also include primers to amplify the β4 (DEC
11) and α2 (DEC 12) bfpA alleles (Blank et al., 2000). While not
included in the samemPCRassay,detection of additional lpfA sub-
types would permit identiﬁcation of EHEC2 and EPEC2 strains, as
well as afford detection of LEE-negative STEC (eae−, stx+, lpfA1-
2+, and/or lpfA2-1+) and atypical EPEC (eae+, bfpA−, lpfA1-2+,
and/or lpfA2-1+). Recent data also supports this notion, as Gomes
et al. (2011) demonstrated that of the lpfA+ atypical EPEC strains
tested, lpfA1-2 and lpfA2-1 were frequently present together in a
given strain. Finally, the lpfA1-1 variant was used to identify typical
EPEC strains; however, this allele was present in only 35% (16/46)
of the isolates tested. Currently, we are exploring the possibility to
incorporate alternative lpfA1 alleles identiﬁed in our initial screen
(Torres et al., 2009) to increase the speciﬁcity of our assay.
In summary, we presented data supporting a mPCR approach
that, with only eight virulence-associated genes, has the poten-
tial detect a wide range of pathogenic E. coli strains. The assay was
testedwith a collectionof clinical isolates, resulting in a highdegree
of agreement between known strain information and the results of
the mPCR. The speciﬁcity and sensitivity of the assay are such that
diagnostic facilities in developing countries can easily incorpo-
rate this methodology into their workﬂow. The mPCR approach
described here has potential for improving both diagnostics and
epidemiological studies involving DEC.
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